Skip to main content

Hans Peter Hasler


Chairman of the Board of Directors since 2009, Member of the Audit Committee, Swiss national

Swiss Federal Commercial Diploma, Marketing Certificate, Swiss School of Business Administration SIB, Zurich; CEO of Vicarius Pharma (2017 to 2020). Prior to this, international management positions at Wyeth Pharmaceuticals (1993 to 2001, Germany and USA), Biogen Inc. (2001 to 2009, Boston) and Elan Corporation (2012 to 2013, Dublin and San Francisco).

Chairman of the Board of Directors Shield Therapeutics plc since 2018 and MIAC AG (non-profit) since 2012. Member of the Board of Directors Gain Therapeutics since 2021 and Minerva Neurosciences since 2017.

Hans Peter Hasler